These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 2258162)

  • 1. Splanchnic vasodilation and renal vasoconstriction: a key to the hepatorenal syndrome?
    Bosch J
    Hepatology; 1990 Dec; 12(6):1445-7. PubMed ID: 2258162
    [No Abstract]   [Full Text] [Related]  

  • 2. Hepatorenal syndrome.
    Bataller R; Arroyo V; Ginès P; Sort P
    Forum (Genova); 1998; 8(1):62-81. PubMed ID: 9565447
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatorenal syndrome.
    Biswas KD; Jain AK
    Trop Gastroenterol; 2002; 23(3):113-6. PubMed ID: 12693150
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatorenal syndrome.
    Kramer L; Hörl WH
    Semin Nephrol; 2002 Jul; 22(4):290-301. PubMed ID: 12118394
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ascites and hepatorenal syndrome: pathogenesis and treatment strategies.
    Ginès P; Arroyo V; Rodés J
    Adv Intern Med; 1998; 43():99-142. PubMed ID: 9506180
    [No Abstract]   [Full Text] [Related]  

  • 6. Splanchnic and systemic vasodilatation: the patient.
    Tsai MH
    J Clin Gastroenterol; 2007; 41 Suppl 3():S266-71. PubMed ID: 17975476
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical Scenarios in Acute Kidney Injury: Hepatorenal Syndrome.
    Meola M; Nalesso F; Petrucci I; Samoni S; Ronco C
    Contrib Nephrol; 2016; 188():33-8. PubMed ID: 27169751
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Treatment of hepatorenal syndrome].
    Guevara M
    Gastroenterol Hepatol; 2003 Apr; 26(4):270-4. PubMed ID: 12681123
    [No Abstract]   [Full Text] [Related]  

  • 9. [Hepatorenal syndrome: pathogenesis and treatment].
    Ashkenazi E; Ilan Y; Shoval D
    Harefuah; 2007 Jun; 146(6):475-9, 499. PubMed ID: 17760404
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regional hemodynamics during postexercise hypotension. I. Splanchnic and renal circulations.
    Pricher MP; Holowatz LA; Williams JT; Lockwood JM; Halliwill JR
    J Appl Physiol (1985); 2004 Dec; 97(6):2065-70. PubMed ID: 15310744
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis. International Ascites Club.
    Arroyo V; Ginès P; Gerbes AL; Dudley FJ; Gentilini P; Laffi G; Reynolds TB; Ring-Larsen H; Schölmerich J
    Hepatology; 1996 Jan; 23(1):164-76. PubMed ID: 8550036
    [No Abstract]   [Full Text] [Related]  

  • 12. Hepatorenal syndrome.
    Bataller R; Ginès P; Guevara M; Arroyo V
    Semin Liver Dis; 1997; 17(3):233-47. PubMed ID: 9308128
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulatory function and hepatorenal syndrome in cirrhosis.
    Ruiz-del-Arbol L; Monescillo A; Arocena C; Valer P; Ginès P; Moreira V; Milicua JM; Jiménez W; Arroyo V
    Hepatology; 2005 Aug; 42(2):439-47. PubMed ID: 15977202
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adaptations in control of blood flow with training: splanchnic and renal blood flows.
    McAllister RM
    Med Sci Sports Exerc; 1998 Mar; 30(3):375-81. PubMed ID: 9526882
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Hepatorenal syndrome].
    Pillebout E
    Nephrol Ther; 2014 Feb; 10(1):61-8. PubMed ID: 24388293
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ET-3 is extracted by and induces potent vasoconstriction in human splanchnic and renal vasculatures.
    Weitzberg E; Hemsén A; Lundberg JM; Ahlborg G
    J Appl Physiol (1985); 1995 Oct; 79(4):1255-9. PubMed ID: 8567570
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The liver and the kidney: mutual clearance or mixed intoxication.
    Arroyo V
    Contrib Nephrol; 2007; 156():17-23. PubMed ID: 17464111
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ETA receptors mediate vasoconstriction, whereas ETB receptors clear endothelin-1 in the splanchnic and renal circulation of healthy men.
    Böhm F; Pernow J; Lindström J; Ahlborg G
    Clin Sci (Lond); 2003 Feb; 104(2):143-51. PubMed ID: 12546636
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatorenal syndrome: a dreaded complication of end-stage liver disease.
    Cárdenas A
    Am J Gastroenterol; 2005 Feb; 100(2):460-7. PubMed ID: 15667508
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Review article: pathogenesis and pathophysiology of hepatorenal syndrome--is there scope for prevention?
    Møller S; Henriksen JH
    Aliment Pharmacol Ther; 2004 Sep; 20 Suppl 3():31-41; discussion 42-3. PubMed ID: 15335398
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.